Journal of Pain and Symptom Management
Volume 39, Issue 4 , Pages 779-783 , April 2010

Paraneoplastic Raynaud's Phenomenon—Good Palliation After a Multidisciplinary Approach

  • Eva K. Schildmann, MD

      Affiliations

    • Department of Hematology, Oncology and Tumor Immunology, Helios Klinikum Berlin-Buch, Berlin, Germany
    • Corresponding Author InformationAddress correspondence to: Eva K. Schildmann, MD, Department of Hematology, Oncology and Tumor Immunology, Robert-Rössle-Klinik, Helios Klinikum Berlin-Buch, Campus Buch, Universitätsmedizin Berlin, Schwanebecker Chaussee 50, 13125 Berlin, Germany.
    • ,
  • Andrew N. Davies, FRCP

      Affiliations

    • Department of Palliative Medicine, Royal Marsden Hospital NHS Foundation Trust, Sutton, Surrey, United Kingdom

,Accepted 28 September 2009.

References 

  1. Smith IE, de Boer RH. Paraneoplastic syndromes other than metabolic. In:  Souhami RL,  Tannock I,  Hohenberger P,  Horiot J-C editor. Oxford textbook of oncology. 2nd ed.. Oxford, UK: Oxford University Press; 2002;p. 933–958
  2. Wigley FM. Raynaud's phenomenon. N Engl J Med. 2002;347:1001–1008
  3. Spencer-Green G. Outcomes in primary Raynaud phenomenon: a meta-analysis of the frequency, rates, and predictors of transition to secondary diseases. Arch Intern Med. 1998;158:595–600
  4. Poszepczynska-Guigné E, Viguier M, Chosidow O, et al. Paraneoplastic acral vascular syndrome: epidemiologic features, clinical manifestations, and disease sequelae. J Am Acad Dermatol. 2002;47:47–52
  5. Wilmalaratna HS, Sachdev D. Adenocarcinoma of the lung presenting with Raynaud's phenomenon, digital gangrene and multiple infarctions in the internal organs. Br J Rheumatol. 1987;26:473–475
  6. Zuber M. Positive antinuclear antibodies in malignancies. Ann Rheum Dis. 1992;51:573–574
  7. Wong AS, Hon Yoon K. Paraneoplastic Raynaud phenomenon and idiopathic thrombocytopenic purpura in non-small-cell lung cancer. Am J Clin Oncol. 2003;26:26–29
  8. Kopterides P, Tsavaris N, Tzioufas A, Pikazis D, Lazaris A. Digital gangrene and Raynaud's phenomenon as complications of lung adenocarcinoma. Lancet Oncol. 2004;5:549
  9. El Mahou S, Sailler L, Madaule S, Arlet P. RACAND syndrome as a paraneoplastic syndrome?. J Clin Rheumatol. 2006;12:104–105
  10. Doll DC, Yarbro JW. Vascular toxicity associated with antineoplastic agents. Semin Oncol. 1992;19:580–596
  11. Raanani P, Ben-Bassat I. Immune-mediated complications during interferon therapy in haematological patients. Acta Haematol. 2002;107:133–144
  12. Westbury CB, Harrington KJ, Rhys-Evans P, et al. Raynaud's phenomenon after radical radiotherapy for tumours of the head and neck. Postgrad Med J. 2003;79:176–177
  13. Herrick AL. Pathogenesis of Raynaud's phenomenon. Rheumatology. 2005;44:587–596
  14. DeCross AJ, Sahasrabudhe DM. Paraneoplastic Raynaud's phenomenon. Am J Med. 1992;92:571–572
  15. Taillan B, Castanet J, Garnier G, et al. Paraneoplastic Raynaud's phenomenon. Clin Rheumatol. 1993;12:281–282
  16. Kohli M, Bennett RM. Raynaud's phenomenon as a presenting sign of ovarian adenocarcinoma. J Rheumatol. 1995;22:1393–1394
  17. Creager MA, Dzau VJ. Vascular diseases of the extremities. In:  Kasper DL,  Fauci AS,  Longo DL, et al. editor. Harrison's principles of internal medicine. 16th ed.. New York: McGraw-Hill; 2005;p. 1489–1491
  18. Pope JE. The diagnosis and treatment of Raynaud's phenomenon: a practical approach. Drugs. 2007;67:517–525
  19. Thompson AE, Pope JE. Calcium channel blockers for primary Raynaud's phenomenon: a meta-analysis. Rheumatology. 2005;44:145–150
  20. Boin F, Wigley FM. Understanding, assessing and treating Raynaud's phenomenon. Curr Opin Rheumatol. 2005;17:752–760
  21. Pope J, Fenlon D, Thompson A, et al. Iloprost and cisaprost for Raynaud's phenomenon in progressive systemic sclerosis. Cochrane Database Syst Rev. 1998;(Issue 2):Art. No.: CD000953
  22. Halpern SM, Todd P, Kirby D. Hodgkin's disease presenting with digital ischaemia. Clin Exp Dermatol. 1994;19:330–331
  23. Lowell RC, Gloviczki P, Cherry KJ, et al. Cervicothoracic sympathectomy for Raynaud's syndrome. Int Angiol. 1993;12:168–172
  24. McCall TE, Petersen DP, Wong LB. The use of digital artery sympathectomy as a salvage procedure for severe ischemia of Raynaud's disease and phenomenon. J Hand Surg Am. 1999;24:173–177

PII: S0885-3924(10)00079-5

doi: 10.1016/j.jpainsymman.2009.09.006

Journal of Pain and Symptom Management
Volume 39, Issue 4 , Pages 779-783 , April 2010

Article Tools

* Image Usage & Resolution